TFF Pharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Austin TX United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04872231
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

TFF Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (1)

tacrolimus (prograf) (1 trial)

Drugs in Phase 1 Trials (2)

niclosamide (nicloside) (1 trial)

voriconazole (vfend) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3